Wojcik B E, Spinks M K, Optenberg S A
Center for Healthcare Education and Studies, Army Medical Department Center and School, Fort Sam Houston, Texas 78234-6125, USA.
Cancer. 1998 Apr 1;82(7):1310-8. doi: 10.1002/(sici)1097-0142(19980401)82:7<1310::aid-cncr14>3.0.co;2-9.
This retrospective review of breast carcinoma cases in the Department of Defense (DoD) Central Tumor Registry evaluated differences in survival patterns between African American and white women treated in U.S. military health care facilities. The study examined the effects of age, stage of cancer, tumor size, grade, lymph node involvement, waiting time between diagnosis and first treatment, marital status, military dependent status, alcohol usage, tobacco usage, and family history of cancer.
Researchers reviewed the tumor registry records of 6577 women (5879 whites and 698 African Americans) diagnosed with breast carcinoma. The patients, ages 19-97 years, were diagnosed between 1975 and 1994. A hazard ratio (relative risk of mortality) model compared African American and white patients, adjusting for various combinations of covariates; impact of independent variables on the risk of death; prognostic factors significantly associated with survival; disease free and overall survival times; effects of ethnicity, stage, and age on survival; and trends in stage at diagnosis. A P value (2-sided) of less than 0.05 was considered statistically significant.
After adjustment for age, the risk of death was 1.45 (95% confidence interval [CI], 1.20-1.76) times greater for African American women than for white women. Adjustment for stage reduced the risk to 1.41 (95% CI, 1.16-1.70); further adjustment for demographic variables and most clinical variables had no effect. Still, African American women treated in the military health care facilities had a better survival rate than African American women represented in the Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute. In our study, the 5-year risk of death, from any cause, was 1.37 for African American women with breast carcinoma; in other words, the mortality rate for African American women was 24.77% compared with 18.08% for white women. In the latest SEER data, the 5-year relative risk of death for African American women compared with white women is 1.86. The mortality rate in SEER is 34.2% for African American women and 18.4% for white women. The survival rate for white DoD beneficiaries is comparable to that for white women in SEER.
These observations suggest that ready access to medical facilities and the full complement of treatment options that are standard for all DoD patients improve survival rates for African American women. However, a significant unexplained difference in survival still exists between African American and white military beneficiaries.
本项对美国国防部中央肿瘤登记处乳腺癌病例的回顾性研究,评估了在美国军事医疗设施接受治疗的非裔美国女性和白人女性在生存模式上的差异。该研究考察了年龄、癌症分期、肿瘤大小、分级、淋巴结受累情况、诊断与首次治疗之间的等待时间、婚姻状况、军属身份、饮酒情况、吸烟情况以及癌症家族史的影响。
研究人员查阅了6577名被诊断为乳腺癌的女性(5879名白人女性和698名非裔美国女性)的肿瘤登记记录。这些患者年龄在19至97岁之间,于1975年至1994年期间被诊断。一个风险比(死亡相对风险)模型对非裔美国患者和白人患者进行了比较,并针对各种协变量组合进行了调整;自变量对死亡风险的影响;与生存显著相关的预后因素;无病生存期和总生存期;种族、分期和年龄对生存的影响;以及诊断时分期的趋势。双侧P值小于0.05被认为具有统计学意义。
在对年龄进行调整后,非裔美国女性的死亡风险比白人女性高1.45倍(95%置信区间[CI],1.20 - 1.76)。对分期进行调整后,风险降至1.41(95% CI,1.16 - 1.70);对人口统计学变量和大多数临床变量进行进一步调整没有效果。不过,在军事医疗设施接受治疗的非裔美国女性的生存率高于美国国立癌症研究所监测、流行病学和最终结果(SEER)项目中的非裔美国女性。在我们的研究中,患有乳腺癌的非裔美国女性因任何原因导致的5年死亡风险为1.37;换句话说,非裔美国女性的死亡率为24.77%,而白人女性为18.08%。在最新的SEER数据中,非裔美国女性与白人女性相比的5年死亡相对风险为1.86。在SEER中,非裔美国女性的死亡率为34.2%,白人女性为18.4%。国防部白人受益人的生存率与SEER中的白人女性相当。
这些观察结果表明,能够随时使用医疗设施以及为所有国防部患者提供的全套标准治疗方案提高了非裔美国女性的生存率。然而,非裔美国和白人军事受益人在生存方面仍存在显著的无法解释的差异。